From Precision Medicine to Personalised Medicine in Oncology: Predicting Effective Treatments Based on Complex Tumour Gene Signatures Using a Novel In Vivo Screening Technology
Time: 4:00 pm
day: Day 2 PM
Details:
- Genetic complexity: Tumours are driven by a network of oncogenic genetic alterations and tumour signatures are incredibly diverse across patient population
- Drosophila avatars: a rapid and cost-effective generation of in vivo models with genetically engineered complex tumour signatures for large-scale drug screening
- Utilising whole-exome sequencing and in vivo drug screening to uncover actionable insights into tumour-specific vulnerabilities: from standard of care ranking to novel combinations
